abstract |
The present invention relates to a short peptide therapeutic agent and a pharmaceutical composition comprising the same, wherein the short peptide therapeutic agent comprises at least one short peptide of the amino acid sequence as shown in SEQ ID NO: 1 and SEQ ID NO: 2, and Any of the short peptides includes no more than 40 amino acid residues to inhibit proliferation, cancer stem cell, migration, invasion, metastasis or drug resistance of cancer cells. |